Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002112 · ClinicalTrials.gov registry record · NA

Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome

A NA study of HIV Infections and Candidiasis, Oral, sponsored by Pfizer.

Completed
Registry status
NA
Development phase
5
Study locations

NCT00002112 is a NA study of HIV Infections and Candidiasis, Oral that has completed, run by Pfizer. The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002112, a NA study of HIV Infections and Candidiasis, Oral, has completed, sponsored by Pfizer.

COMPLETED
Registry status
NA
Development phase
5
Study locations

Study Summary

To compare the efficacy, safety, and toleration of fluconazole as a single daily oral suspension for 14 days versus nystatin oral suspension 4 times daily for 14 days in the treatment of oropharyngeal candidiasis in patients with AIDS or HIV infection.

Conditions Studied

HIV Infections Candidiasis, Oral

Interventions

  • DRUG Fluconazole
  • DRUG Nystatin

Study Locations (5)

California

  • California Med Research Group - Fresno
  • UCSF Hosp - San Francisco

Maryland

  • Johns Hopkins School of Medicine - Baltimore

Pennsylvania

  • Med College of Pennsylvania - Philadelphia

Virginia

  • Hampton Roads Med Specialists - Hampton

Trial Details

FieldValue
Phase NA

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00002112

The ClinicalTrials.gov registry entry for NCT00002112 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Fluconazole is the first listed.

NCT00002112 reports 5 study locations spanning 4 distinct geographic areas - top geographies include California, Maryland, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00002112 about?

NCT00002112 is a clinical study titled "Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome". To compare the efficacy, safety, and toleration of fluconazole as a single daily oral suspension for 14 days versus nystatin oral suspension 4 times daily for 14 days in the treatment of oropharyngeal candidiasis in patients with AIDS or HIV infection.

What is the current status of trial NCT00002112?

This trial is currently completed. It is a NA study.

What conditions does trial NCT00002112 study?

This clinical trial studies the following conditions: HIV Infections, Candidiasis, Oral.

What interventions are being tested in trial NCT00002112?

The interventions under investigation include: Fluconazole (DRUG), Nystatin (DRUG).

Who is sponsoring clinical trial NCT00002112?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002112 being conducted?

This trial has 5 study locations across California, Maryland, Pennsylvania, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Candidiasis, Oral

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.